A multi-analyte blood test, CancerSEEK, can detect 8 common cancer types, with high sensitivity and specificity.
Both patients with and without BRCA mutations have comparable survival rates.
For women who work night shifts, breast cancer risks increase by 3.3% for every 5 years of work.
Breast cancer diagnosis is higher among women who currently use or recently used contemporary hormonal contraceptives than among women who have never used hormonal contraceptives.
Consensus regarding mammography screening varies, and conflicting guidelines from medical organizations can cause confusion for patients and providers.
A variety of non-hormone options and therapies are available for treatment of estrogen-depletion symptoms and clinical problems after a diagnosis of breast cancer.
Thousands of US lives would be saved each year if women received annual mammograms starting at age 40.
Breast cancer risk is increased with a larger number of first- and second-degree relatives diagnosed as having breast cancer for both BRCA1/BRCA2 carriers.
A breast cancer screening program helped improve mammography referral and screening rates in a federally qualified health center.
Drinking the equivalent of a small glass of wine or beer a day increases pre-menopausal breast cancer risk by 5% and post-menopausal breast cancer risk by 9%.
Developing breast cancer was associated inversely with taking 3 or more tablets of low-dose aspirin per week.
Evidence supports the routine use of mind-body practices, such as yoga, meditation, relaxation techniques, and passive music therapy, to address common mental health concerns in patients with breast cancer.
Nearly 70% of participants who self-administered acupressure therapy experienced improved levels of fatigue.
As breast cancer survivorship increases, NPs have taken on long-term patient care.
Extending adjuvant aromatase inhibitor treatment can decrease disease recurrence and increase survival in breast cancer patients.
Fruit intake in adolescence may be associated with decreased breast cancer rates in adulthood.
The combination of tomosynthesis and digital mammography screening may benefit women with heterogeneously dense breasts.
50% of women studied met the American Cancer Society requirements for early mammography screening.
Despite the guideline, clinicians may choose to order MRI's for patients with dense breasts.
Primary care clinicians should be proficient at assessing the potential for hereditary breast cancer risk in their patients.
In an update to its 2009 recommendations, the U.S. Preventive Services Task Force has presented its final guidelines on mammography screening for breast cancer.
Denosumab may reduce the risk of fracture in women with breast cancer on aromatase inhibitor therapyJanuary 06, 2016
Denosumab has been shown to reduce fracture risk in women with breast cancer with bone metastases.
False-positive results on a screening mammogram are associated with a greater risk of developing breast cancer in the 10 years following the result.
A new study of women with at least 2 risk factors for breast cancer found that ultrasound and mammography have similar breast cancer detection rates.
Postmenopausal women especially former smokers who quit within the last 20 years have an increased risk of postmenopausal breast cancer associated with periodontal disease.
In a study of over 278,000 patients with stage 1 through stage 3 breast cancer, African American women had the lowest rate of pathologic complete response.
Digital screening mammography is as accurate without computer-aided detection (CAD) as it is with the technology.
Data released by the American Cancer Society show that, for the first time, breast cancer incidence is nearly identical in black and white women.
New guidelines from the American Cancer Society suggest that to combat overdiagnosis, women begin mammography screening for breast cancer at age 45 and continue yearly through age 54 before transitioning to a biannual screening plan.
Women who receive genetic counseling prior to undergoing BRCA testing display more knowledge of both the testing process and of the potential results.